MD, PhD
Distinguished Professor and the Robert B. Jaffe MD Endowed Professor in Reproductive Sciences at the University of California, San Francisco (UCSF). Director, UCSF Stanford Endometriosis Center for Discovery, Innovation, Training, and Community engagement.
MD
Professor of Reproductive Sciences, Co-Director of the Oxford Endometriosis CaRe Centre, and a Consultant Gynaecologist.
MD, MPH
Robert K Ferguson and Virginia A Ferguson Professor of Obstetrics and Gynecology at the University of Michigan. Co-Chief of Gynecology, Section Head of the Minimally Invasive Gynecologic Surgery Program, and Director of the Endometriosis and Chronic Pelvic Pain Consultative Clinic.
MD, PhD
Head of the Gynecology Research Unit at UCLouvain, Chief of Clinic at Saint-Luc University Clinics, Full Professor, and a Clinical Researcher with the FNRS (F.R.S.-FNRS)
Gesynta Pharma bases its R&D on groundbreaking research from the Karolinska Institutet.
The members of Gesynta Pharma's management team and board of directors have extensive experience from drug development and commercialization.
Endometriosis is a chronic, inflammatory, estrogen-dependent disease affecting millions of women worldwide.
Our lead drug candidate vipoglanstat is in clinical phase 2 for endometriosis, while GS-073 is ready to enter clinical phase 1 for chronic inflammatory pain.